Carl Zeiss Meditec AG (CZMWY)
USD 48.09
(-1.39%)
USD 48.09
(-1.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 501.87 Million EUR | 3.94% |
| 2022 | 482.85 Million EUR | 17.77% |
| 2021 | 409.99 Million EUR | 53.54% |
| 2020 | 267.03 Million EUR | -6.78% |
| 2019 | 286.43 Million EUR | 36.0% |
| 2018 | 213.12 Million EUR | 1.77% |
| 2017 | 206.95 Million EUR | 24.23% |
| 2016 | 165.78 Million EUR | 23.26% |
| 2015 | 135.15 Million EUR | -0.21% |
| 2014 | 135.43 Million EUR | -21.67% |
| 2013 | 168.39 Million EUR | 23.36% |
| 2012 | 140.15 Million EUR | 10.37% |
| 2011 | 126.99 Million EUR | 15.63% |
| 2010 | 109.78 Million EUR | 8.76% |
| 2009 | 100.98 Million EUR | 7.23% |
| 2008 | 94.16 Million EUR | -0.17% |
| 2007 | 94.32 Million EUR | -71.48% |
| 2006 | 59.69 Million EUR | 18.06% |
| 2005 | 280.15 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 57.38 Million EUR | -20.28% |
| 2024 Q2 | 75.39 Million EUR | 28.66% |
| 2024 Q1 | 58.6 Million EUR | -51.01% |
| 2023 Q3 | 135.61 Million EUR | 39.14% |
| 2023 Q2 | 97.46 Million EUR | 28.41% |
| 2023 Q4 | 119.61 Million EUR | -11.8% |
| 2023 Q1 | 75.9 Million EUR | -47.39% |
| 2023 FY | - EUR | 3.94% |
| 2022 FY | - EUR | 17.77% |
| 2022 Q1 | 56.1 Million EUR | -30.24% |
| 2022 Q2 | 122.24 Million EUR | 117.9% |
| 2022 Q3 | 90.47 Million EUR | -25.99% |
| 2022 Q4 | 144.28 Million EUR | 59.48% |
| 2021 FY | - EUR | 53.54% |
| 2021 Q1 | 68.4 Million EUR | -28.6% |
| 2021 Q2 | 81.13 Million EUR | 18.62% |
| 2021 Q3 | 118.43 Million EUR | 45.96% |
| 2021 Q4 | 80.41 Million EUR | -32.1% |
| 2020 Q4 | 95.8 Million EUR | 968.18% |
| 2020 Q1 | 58.7 Million EUR | -15.26% |
| 2020 Q2 | 43.14 Million EUR | -26.5% |
| 2020 Q3 | 8.96 Million EUR | -79.21% |
| 2020 FY | - EUR | -6.78% |
| 2019 Q2 | 50.26 Million EUR | 19.67% |
| 2019 Q1 | 42 Million EUR | -29.1% |
| 2019 Q4 | 69.26 Million EUR | -9.53% |
| 2019 FY | - EUR | 36.0% |
| 2019 Q3 | 76.56 Million EUR | 52.34% |
| 2018 Q4 | 59.24 Million EUR | 59.52% |
| 2018 Q1 | 39.1 Million EUR | -9.33% |
| 2018 Q2 | 46.31 Million EUR | 18.44% |
| 2018 Q3 | 37.13 Million EUR | -19.81% |
| 2018 FY | - EUR | 1.77% |
| 2017 Q2 | 48.36 Million EUR | 5.59% |
| 2017 Q4 | 43.12 Million EUR | -5.0% |
| 2017 Q3 | 45.39 Million EUR | -6.14% |
| 2017 Q1 | 45.8 Million EUR | -6.79% |
| 2017 FY | - EUR | 24.23% |
| 2016 Q1 | 33.48 Million EUR | -11.21% |
| 2016 Q2 | 50.08 Million EUR | 49.58% |
| 2016 Q4 | 49.13 Million EUR | 44.97% |
| 2016 Q3 | 33.89 Million EUR | -32.32% |
| 2016 FY | - EUR | 23.26% |
| 2015 Q3 | 39.12 Million EUR | 60.06% |
| 2015 Q1 | 33.87 Million EUR | 30.32% |
| 2015 FY | - EUR | -0.21% |
| 2015 Q2 | 24.44 Million EUR | -27.86% |
| 2015 Q4 | 37.7 Million EUR | -3.61% |
| 2014 Q3 | 30.45 Million EUR | -26.78% |
| 2014 FY | - EUR | -21.67% |
| 2014 Q2 | 41.59 Million EUR | 11.28% |
| 2014 Q4 | 25.99 Million EUR | -14.65% |
| 2014 Q1 | 37.38 Million EUR | -25.89% |
| 2013 Q3 | 41.38 Million EUR | 11.44% |
| 2013 Q4 | 50.44 Million EUR | 21.89% |
| 2013 FY | - EUR | 23.36% |
| 2013 Q2 | 37.13 Million EUR | -15.49% |
| 2013 Q1 | 43.93 Million EUR | 10.7% |
| 2012 Q2 | 42.87 Million EUR | 36.07% |
| 2012 Q1 | 31.5 Million EUR | 2.19% |
| 2012 Q4 | 39.69 Million EUR | 20.91% |
| 2012 Q3 | 32.82 Million EUR | -23.43% |
| 2012 FY | - EUR | 10.37% |
| 2011 Q4 | 30.83 Million EUR | 0.9% |
| 2011 Q1 | 28.91 Million EUR | -26.41% |
| 2011 Q2 | 36.69 Million EUR | 26.9% |
| 2011 Q3 | 30.55 Million EUR | -16.71% |
| 2011 FY | - EUR | 15.63% |
| 2010 Q3 | 22.59 Million EUR | -8.28% |
| 2010 Q4 | 39.29 Million EUR | 73.93% |
| 2010 FY | - EUR | 8.76% |
| 2010 Q1 | 23.32 Million EUR | -21.44% |
| 2010 Q2 | 24.62 Million EUR | 5.6% |
| 2009 Q2 | 24.04 Million EUR | -11.06% |
| 2009 Q3 | 20.2 Million EUR | -15.98% |
| 2009 Q4 | 29.68 Million EUR | 46.92% |
| 2009 FY | - EUR | 7.23% |
| 2009 Q1 | 27.03 Million EUR | 0.0% |
| 2008 FY | - EUR | -0.17% |
| 2007 FY | - EUR | -71.48% |
| 2006 FY | - EUR | 18.06% |
| 2005 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 52164.414% |
| Ansell Limited | 209.86 Million USD | -139.147% |
| Ansell Limited | 206.3 Million USD | -143.275% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -1071.52% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 30985.67% |
| Psykey, Inc. | -1.29 Million USD | 38845.885% |
| ConvaTec Group Plc | 455.5 Million USD | -10.182% |
| ConvaTec Group Plc | 455.5 Million USD | -10.182% |
| Encision Inc. | -544.19 Thousand USD | 92323.743% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 354008.046% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 456642.345% |
| Innovative MedTech Inc. | -7.67 Million USD | 6640.122% |
| LifePoint, Inc. | -14.2 Million USD | 3633.813% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 8211.799% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 154523.692% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 233277.379% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 123780.825% |
| SmileDirectClub, Inc. | -186.13 Million USD | 369.625% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -12.07% |
| SheerVision, Inc. | -110.53 Thousand USD | 454159.947% |
| United Health Products, Inc. | -2.5 Million USD | 20157.317% |
| Vasamed, Inc. | -4.57 Million USD | 11071.327% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 22299.717% |
| Yubo International Biotech Limited | -1.17 Million USD | 42715.519% |